Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-299888
Filing Date
2011-11-07
Accepted
2011-11-07 16:34:10
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d251597d10q.htm 10-Q 222359
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) d251597dex311.htm EX-31.1 9153
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) d251597dex312.htm EX-31.2 9153
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 d251597dex321.htm EX-32.1 3310
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 d251597dex322.htm EX-32.2 3310
  Complete submission text file 0001193125-11-299888.txt   1163744

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT appa-20110930.xml EX-101.INS 124380
7 XBRL TAXONOMY EXTENSION SCHEMA appa-20110930.xsd EX-101.SCH 10286
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appa-20110930_cal.xml EX-101.CAL 19710
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appa-20110930_def.xml EX-101.DEF 6575
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE appa-20110930_lab.xml EX-101.LAB 84263
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appa-20110930_pre.xml EX-101.PRE 56493
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 111185037
SIC: 2834 Pharmaceutical Preparations